Clinical Trial Update: Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating growth hormone treatment in children who are small for gestational age reports efficacy and safety results; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Small For Gestational Age

Drugs mentioned

• GENOTROPIN (SOMATROPIN)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Foetal Growth Problem, Small for Gestational Age | Phase 3 | Status: COMPLETED